Ligand profile
ML1
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_2684 — ribosyldihydronicotinamide dehydrogenase (quinone)
Identifiers
Database identifiers and provenance.
- Ligand ID
ML1- PDB
2qwx- UniProt (similar protein)
P16083- Target protein
- VK055_2684
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 54.1
- −1 ≤ LogP ≤ 5 1.86
- MW ≤ 500 Da 232.3
- LogP ≤ 5 1.86
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 54.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(=O)NCCc1c[nH]c2c1cc(cc2)OCCC(=O)NCCc1c[nH]c2c1cc(cc2)OC
InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)
DRLFMBDRBRZALE-UHFFFAOYSA-NDRLFMBDRBRZALE-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF02525
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand ML1 →
- PDB RCSB structure 2qwx →
- UniProt UniProt P16083 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ML1”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_2684.
PDB 59
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).